About
Kuros Biosciences Ag (SW:KURN) — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 13 2026
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
Dec 2 2025
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
Nov 26 2025
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
Oct 16 2025
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
Sep 30 2025
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
Financials
Revenue
CHF146.06 M
Market Cap
CHF898.77 M
P/E Ratio
382.33
EPS
0.06
Translate